Globus Medical, Inc. Class A (GMED) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Globus Medical, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.797 Welcome to Globus Medical's second quarter 2025 earnings call. 00:00:04.797 -- 00:00:08.903 At this time, all lines will be on mute, and a question and answer session will be held 00:00:08.903 -- 00:00:11.166 after the prepared remarks. 00:00:11.166 -- 00:00:15.932 I will now turn the call over to Brian Kearns, Senior Vice President of Business Development 00:00:15.932 -- 00:00:20.616 and Investor Relations. Mr. Kearns, please go ahead. 00:00:20.839 -- 00:00:24.844 Thank you, Haley, and thank you, everyone, for joining us today. 00:00:24.844 -- 00:00:29.350 Joining today's call from Globus Medical will be David Paul, Globus founder and executive 00:00:29.350 -- 00:00:34.779 chairman. Keith Pfeil, President and Chief Executive Officer, and Kyle Klein, 00:00:34.779 -- 00:00:37.700 Chief Financial Officer. 00:00:37.722 -- 00:00:42.027 This review is being made available via webcast accessible through the Investor Relations 00:00:42.027 -- 00:00:46.630 section of the Globus Medical website at www.globusmedical.com. 00:00:47.833 -- 00:00:52.639 Before we begin, let me remind you that some of the statements made during this review 00:00:52.639 -- 00:00:55.522 are or may be considered forward-looking statements. 00:00:55.522 -- 00:01:00.705 Our Form 10-K for the 2024 fiscal year and our subsequent filings with the Securities 00:01:00.705 -- 00:01:05.650 and Exchange Commission identify certain factors that could cause our actual results 00:01:05.650 -- 00:01:10.836 to differ materially from those projected in any forward-looking statements made today. 00:01:10.836 -- 00:01:15.121 Our SEC filings, including the 10-K, are available on our website. 00:01:15.121 -- 00:01:19.726 We do not undertake to update any forward-looking statements as a...